GENE ONLINE|News &
Opinion
Blog

Olaparib
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
LATEST
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
Rising Bird Flu Cases in Cattle and Humans Drive Global Efforts in Vaccination, Genetic Monitoring, and Surveillance
2024-07-17
STLI Webinar Series 1: Experts Discuss Regulatory Trends in Regenerative Medicine
2024-07-16
Wistar and Accelerated Biosciences Partner to Develop Novel hTSCs Platform for Immunotherapies
2024-07-15
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
EVENT
Scroll to Top